93 related articles for article (PubMed ID: 2397536)
1. [Immunohistochemical and immunoelectron microscopic observation of human lung carcinomas using biotinized peanut lectin (PNA)].
Hou WY
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Apr; 13(2):85-7, 126-7. PubMed ID: 2397536
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
3. CD34-positive stromal cells in primary lung carcinomas.
Nakayama H; Enzan H; Yamamoto M; Miyazaki E; Hidaka C; Okumichi T; Okumichi A; Kajihara H
Oncol Rep; 2003; 10(5):1313-6. PubMed ID: 12883699
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
6. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
[TBL] [Abstract][Full Text] [Related]
7. Elastosis in lung carcinoma: Immunohistochemical, ultrastructural and clinical studies.
Fukushima M; Fukuda Y; Kawamoto M; Yamanaka N
Pathol Int; 2000 Dec; 50(12):1004-13. PubMed ID: 11123770
[TBL] [Abstract][Full Text] [Related]
8. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
9. [Expression of annexin I in different histological types of carcinomas].
Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff H; Saukkonen K; Anttila S; Karjalainen A; Vainio H; Ristimäki A
Cancer Res; 1998 Nov; 58(22):4997-5001. PubMed ID: 9823297
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
13. The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas.
Ten Have-Opbroek AA; Benfield JR; van Krieken JH; Dijkman JH
Histol Histopathol; 1997 Apr; 12(2):319-36. PubMed ID: 9151120
[TBL] [Abstract][Full Text] [Related]
14. Lectin histochemistry of normal lung and pulmonary adenocarcinoma.
Kawai T; Greenberg SD; Titus JL
Mod Pathol; 1988 Nov; 1(6):485-92. PubMed ID: 3222257
[TBL] [Abstract][Full Text] [Related]
15. hnRNP B1 expression in benign and malignant lung disease.
Snead DR; Perunovic B; Cullen N; Needham M; Dhillon DP; Satoh H; Kamma H
J Pathol; 2003 May; 200(1):88-94. PubMed ID: 12692846
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural and molecular heterogeneity in non-small cell lung carcinomas: study of 110 cases and review of the literature.
Bombí JA; Martínez A; Ramírez J; Grau JJ; Nadal A; Fernández PL; Palacín A; Cardesa A
Ultrastruct Pathol; 2002; 26(4):211-8. PubMed ID: 12227946
[TBL] [Abstract][Full Text] [Related]
17. Expression of thyroid transcription factor-1 in normal and neoplastic lung tissues.
Nakamura N; Miyagi E; Murata S; Kawaoi A; Katoh R
Mod Pathol; 2002 Oct; 15(10):1058-67. PubMed ID: 12379752
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
19. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
[TBL] [Abstract][Full Text] [Related]
20. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
